D39.2

Clinical Causes: Genetic mutations affecting trophoblastic cells Abnormal fertilization processes leading to abnormal placental tissue growth Previous molar pregnancies increasing the risk of abnormal placental proliferation Hormonal influences that promote abnormal trophoblastic proliferation Environmental factors and exposure to certain chemicals, though less clearly defined

Key Symptoms: Vaginal bleeding during pregnancy, which may be heavy or irregular Persistent or increasing uterine size inconsistent with gestational age Unusual passing of tissue or fluid from the vagina Enlarged uterus that feels abnormally large or firm Symptoms of anemia in cases of significant bleeding, such as fatigue and pallor Rarely, symptoms related to metastasis if the neoplasm becomes invasive or malignant

Diagnosis Path: Diagnosis of a placental neoplasm of uncertain behavior involves a combination of clinical assessment, imaging techniques, and laboratory tests: - **Ultrasound examination:** Essential for visualizing placental tissue abnormalities, detecting mass formations, and assessing invasiveness. - **Serum beta-hCG levels:** Elevated levels may suggest trophoblastic activity but are not solely diagnostic. - **Histopathological analysis:** Confirmatory diagnosis often requires tissue examination obtained through biopsy or after surgical removal, revealing the characteristics of the trophoblastic tissue. - **Additional imaging:** MRI or CT scans may be employed if there is concern about invasive growth or metastasis. Close monitoring and serial assessments are crucial for tracking the progression or regression of the placental growth.

Treatment Protocols: Management of a neoplasm of uncertain behavior of the placenta depends on its size, extent, and the presence of invasive features: - **Surgical removal:** Dilation and curettage (D&C) may be performed to evacuate abnormal tissue, especially if the neoplasm appears confined. - **Chemotherapy:** May be indicated if there is evidence of invasive growth or malignant transformation, particularly for malignant hydatidiform moles. - **Follow-up care:** Regular monitoring of beta-hCG levels post-treatment to ensure complete resolution and detect any recurrence. - **Additional therapies:** In cases with invasive or metastatic disease, multidisciplinary approaches including targeted therapies or radiation may be considered. Early detection and appropriate intervention are vital to prevent progression to malignancy or other complications.